Regeneron Pharmaceuticals Inc

NAS:REGNHealthcareCBOE:SPESGNASDAQ:NBI

$782.04−1.10%At closeAt close · Tue 20 Oct · ≈ AED 2,872.04 · Market cap $80.51B · Next earnings Wed 28 Oct · Extended $780.00 −0.26%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	84.0%	83.1%	86.0%	82.9%	86.1%	85.4%	—	—
Operating margin	42.1%	55.7%	44.2%	33.2%	28.1%	24.9%	24.9%	+0.0 pts
Net margin	41.3%	50.2%	35.6%	30.1%	31.1%	31.4%	31.4%	+0.0 pts
EBITDA margin	48.3%	60.2%	43.2%	35.8%	37.4%	40.6%	—	—
Return on equity	31.9%	43.0%	19.1%	15.2%	15.0%	14.4%	14.4%	+0.0 pts
Return on assets	20.5%	31.7%	14.9%	12.0%	11.7%	11.1%	11.1%	+0.0 pts
Return on capital employed	24.7%	41.6%	20.7%	14.7%	11.8%	9.9%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	15.7%	10.6%	9.2%	8.2%	7.2%	6.7%	—	—
Interest coverage	62.9×	156.1×	90.7×	59.6×	72.3×	81.7×	—	—
Current ratio	3.6×	3.6×	5.1×	5.7×	4.7×	4.1×	4.1×	+0.0%
Quick ratio	2.9×	3.1×	4.3×	4.9×	3.9×	3.4×	—	—
Cash ratio	0.8×	0.7×	1.0×	0.8×	0.6×	0.7×	0.7×	+0.0%
Asset turnover	0.5×	0.6×	0.4×	0.4×	0.4×	0.4×	—	—
Inventory turnover	0.7×	1.4×	0.7×	0.9×	0.6×	0.7×	—	—
Receivables turnover	2.1×	2.7×	2.3×	2.3×	2.3×	2.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	8.2%	—	—